Cancer and Herbs
- 8 June 2000
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (23), 1742-1743
- https://doi.org/10.1056/nejm200006083422309
Abstract
Bestselling books perpetuate the myth that natural products such as herbs and other “dietary supplements” tend to be safer than conventional medicines.1 Once relegated to health food stores, these products now fill pharmacy and supermarket shelves. So-called natural substances are more popular than ever. Fueled by congressional passage of the Dietary Supplement Health and Education Act of 1994,2 which deregulated the industry by limiting the role of the Food and Drug Administration (FDA), the popularity of dietary supplements has created a $15-billion-a-year industry.In this issue of the Journal, Nortier et al. present evidence of an association between the use . . .Keywords
This publication has 6 references indexed in Scilit:
- Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)New England Journal of Medicine, 2000
- Urothelial lesions in Chinese-herb nephropathyAmerican Journal of Kidney Diseases, 1999
- Urologic cancers in Uremic patientsAmerican Journal of Kidney Diseases, 1995
- Pathologic Aspects of a Newly Described Nephropathy Related to the Prolonged Use of Chinese HerbsAmerican Journal of Kidney Diseases, 1994
- Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbsThe Lancet, 1993
- The carcinogenic action of aristolochic acid in ratsArchives of Toxicology, 1982